Colorectal cancer screening in an equal access healthcare system

Journal of Cancer

Volumn 4, Issue 3, 2013, Pages 270-280

  DeBarros, Mia ^a   Steele, Scott R ^a  

^a Madigan Healthcare System   (United States)

Author keywords

Colonoscopy; Colorectal cancer; Flexible sigmoidoscopy; FOBT; Military healthcare system; Screening; VA

Indexed keywords

BARIUM; DNA; HEME; HEMOGLOBIN;

ARMY; BARIUM ENEMA; CANCER MORTALITY; CANCER SCREENING; COLONOSCOPY; COLORECTAL CANCER; COMPUTED TOMOGRAPHIC COLONOGRAPHY; COST EFFECTIVENESS ANALYSIS; HEALTH CARE; HEALTH CARE ACCESS; HEALTH CARE DISPARITY; HEALTH CARE ORGANIZATION; HEALTH CARE POLICY; HEALTH CARE UTILIZATION; HUMAN; IMMUNOCHEMISTRY; MINORITY GROUP; OCCULT BLOOD; PRACTICE GUIDELINE; PREDICTIVE VALUE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SENSITIVITY AND SPECIFICITY; SIGMOIDOSCOPY; SYSTEMATIC REVIEW;

EID: 84882981995     PISSN: None     EISSN: 18379664     Source Type: Journal    
DOI: 10.7150/jca.5833     Document Type: Review

References (113)

1. [Internet] US Cancer Statistics Working Group. United States Cancer Statistics (USCS): 1999-2007 incidence and mortality data. http://www.cdc.gov/uscs.
2. Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002. CA Cancer J Clin. 2005; 55(2): 74-108.
3. [Internet] http://seer.cancer.gov/csr/1975_2009_pops09/results_single/sect_01_table.01.pdf.
4. Mariotto AB, Yabroff KR, Shao Y, Feuer EJ, Brown ML. Projections of the cost of cancer care in the United States: 2010-2020. J Natl Cancer Inst 2011; 103:117-28.
5. Ekwueme DU, Guy GP, Li C, Rim SH, Parelkar P, Chen SC. The health burden and economic costs of cutaneous melanoma mortality by race/ethnicity-United States, 2000-2006. J Am Acad Derm 2011 Nov; 65(5 Suppl 1): S133-43.
6. Lansdorp-Vogelaar I, van Ballegooijen M, Zauber AG, Habbema JD, Kuipers EJ. Effect of rising chemotherapy costs on the cost savings of colorectal cancer screening. J Natl Cancer Inst 2009; 101:1412-22.
7. Richardson LC, Tai E, Sun HR, Djenaba J and Plescia M. Vital Signs: Colorectal Cancer Screening, Incidence, and Mortality -- United States, 2002-2010. Weekly 2011; 60(26):884-889.
8. [Internet] US Preventive Services Task Force. Screening for colorectal cancer. Rockville, MD: Agency for Healthcare Research and Quality; 2008. http://www.uspreventiveservicestaskforce.org/uspstf/uspscolo.htm.
9. Hofstad B, Vatn M. Growth rate of colon polyps and cancer. Gastointest Endosc Clin N Am 1997; 7:345-363.
10. Winawer SJ, Fletcher RH, Miller L, et al. Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology 1997; 112:594.
11. Force Screening for colorectal cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2008; 149:627.
12. Wong JL, Hawkins NJ, Ward RL. Colorectal Cancer: A Model for Epigenetic Tumorigenesis. Gut 2007; 56:140-148.
13. [Internet] US Department of Health and Human Services. Healthy people 2020. http://www.healthypeople.gov/2020/topicsobjectives2020/default.aspx.
14. Hardcastle JD, Chanberlain JO, Robinson MH et al. Randomized controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 1996; 348:1472-1477.
15. Kronborg O, Fenger C, Olsen J, et al. Randomized study of screening for colorectal cancer with faecal-occult-blood test. Lancet 1996; 348:1467-1471.
16. Wilson JM and Junger G. Principles and Practice of Screening for Disease. Geneva, Switzerland: World Health Organization; 1968.
17. Allison JE. Fecal Occult Blood Testing for Colorectal Cancer. Alim Pharm Ther 1998; 12(1): 1-10.
18. Gopalswanny N, Stelling HP, Markert RJ, et al. A comparative study of eight fecal occult blood tests and HemoQuant in patients in whom colonoscopy is indicated. Arch Fam Med 1994; 3: 1043-1048.
19. Greenberg PD, Bertario L, Gnauk R, et al. A prospective multicenter evaluation of new fecal occult blood tests in patients undergoing colonoscopy. Am J Gastroenterol 2000; 95:1331-1338.
20. Levi Z, Rozen P, Hazazi R, et al. A quantitative immunochemical fecal occult blood test for colorectal neoplasia. Ann Intern Med 2007; 146:244-255.
21. Smith A, Young GP, Cole SR, et al. Comparison of a brush-sampling fecal immunochemical test for hemoglobin with a sensitive guaiac-based fecal occult blood test in detection of colorectal neoplasia. Cancer 2006; 107:2152-2159.
22. Wong BC, Wong WM, Cheung KL, et al. A sensitive guaiac faecal occult blood test is less useful than an immunochemical test for colorectal cancer screening in a Chinese population. Aliment Pharmacol Ther 2003; 18:941-946.
23. Petrelli N, Michalek AM, Freedman A, Baroni M, Mink I, Rodriguez- Bigas M. Immunochemical versus guaiac occult blood stool tests: results of a community-based screening program. Surg Oncol 1994; 3: 27- 36.
24. St. John DJB, Young GP, Alexeyeff MA, et al. Evaluation of new occult blood tests for detection of colorectal neoplasia. Gastroenterology 1993; 104:1661-8.
25. Robinson MHE, Marks CG, Farrands PA, Thomas WM, Hardcastle JD. Population screening for colorectal cancer:comparison between guaiac and immunological faecal occult blood tests. Br J Surg 1994; 81:448-51.
26. Allison JE, Tekawa IS, Ransom LJ, Adrain AL. A comparison of fecal occult-blood tests for colorectal-cancer screening. N Engl J Med 1996; 334:155-9.
27. Miller S and Steele SR. Novel Molecular Screening Approaches in Colorectal Cancer. J Surg Oncol 2012; 105 (5):459-67.
28. Levin B, Hess K, Johnson C. Screening for colorectal cancer:a comparison of three fecal occult blood tests. Arch Intern Med 1997; 157:970-6.
29. Hoff G, Grotmol T, Skovlund E, et al. Risk of colorectal cancer seven years after flexible sigmoidoscopy screening:randomized controlled trial. BMJ 2009;338:b1846
30. Thiis-Evensen E, Hoff GS, Sauar J, et al. Population-based surveillance by colonoscopy:effect on the incidence of colorectal cancer. Telemark Polyp Study I. Scand J Gastroenterol 1999;34 (4):414-20
31. Atkin WS, Edwards R, Kralj-Hans I, et al. Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer:a multicentre randomized controlled trial. Lancet 2010;375 (9726):1624-33
32. Imperiale TF, Wagner DR, Lin CY, et al. Risk of advanced proximal neoplasms in asymptomatic adults according to the distal colorectal findings. N Engl J Med 2000; 343:169-174.
33. Lieberman DA, Weiss DG, Bond JH, et al. Use of colonoscopy to screen asymptomatic adults for colorectal cancer. Veterans Affairs Cooperative Study Group 380. N Engl J Med 2000; 343:162-168.
34. Muller AD, Sonnenberg A. Prevention of colorectal cancer by flexible endoscopy and polypectomy. A case-control study of 32,702 veterans. Ann Intern Med 1995; 123:904-910.
35. Winawer SJ, Zauber AG, Ho MN, et al. Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N Engl J Med 1993; 329:1977-1981
36. Vining, DJ. Virtual endoscopy:Is it a reality?. Radiology 1996; 200:30.
37. Zauber AG, Levin TR, Jaffe CC, Galen BA, Ransohoff DF and Brown ML. Implications of New Colorectal Cancer Screening Technologies for Primary Care Practice. Medical Care 2008; 46:138-146.
38. Levin B, Lieberman DA, McFarland B, et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008:a joint guideline from the American Cancer Society, the US Multi- Society Task Force on Colorectal Cancer, and the American College of Radiology. CA Cancer J Clin 2008; 58:130.
39. Rex DK, Johnson DA, Anderson JC, et al. American College of Gastroenterology guidelines for colorectal cancer screening 2008. Am J Gastroenterol 2009; 104:739-750.
40. Coady-Fariborzian L, Angel LF, Procaccino JA, et al. Perforated colon secondary to virtual colonoscopy:report of a case. Dis Colon Rectum 2004; 47(7):1247-9.
41. Kamar M, Portno O, Bar-Dayan A, et al. Actual colonic perforation in virtual colonoscopy:report of a case. Dis Colon Rectum 2004; 47:1242-1246.
42. Atalla MA, Rozen WM, Master M, McLaughlin S. Colonic perforation during 'virtual' CT colonography. J Gastrohepatol 2009; 24 (11):1800.
43. Bassett JT, Liotta RA, Barlow D, Lee D, et al. Colonic perforation during screening CT colonography using automated CO2 insufflation in an asymptomatic adult. Adom Imaging. 2008; 33(5):598-600.
44. Belo-Oliveira P, Curvo-Semedo L, Rodrigues H, Belo-Soares P, et al. Sigmoid Colon Perforation at CT Colonography Secondary to a Possible Obstructive Mechanism:Report of a Case. Dis Col Rectum. 2007; 50(9):1478-1480.
45. Khan JS, Moran BJ. Iatrogenic Perforation at Colonic Imaging. Colorectal Dis 2011 May; 13(5):481-93.
46. Sosna J, Blachar A, Amitai M, Barmeir A, et al. Colonic Perforation at CT Colonography:Assessment of Risk in a Multicenter Large Cohort. J Rad. 2006; 239(2):457-463.
47. Veerappan GR, Cash BD. Should computed tomographic colonography replace optical colonoscopy in screening for colorectal cancer? Polskie Archiwum Medycyny Wewnetrznej 2009; 119:236-240.
48. Cotton PB, Durkalski VL, Pineau BC, et al. Computed tomographic colonography (virtual colonoscopy):a multicenter comparison with standard colonoscopy for detection of colorectal neoplasia. JAMA 2004; 291:1713-1719.
49. Mulhall, BP, Veerappan GR, Jackson, JL. Meta-analysis:computed tomographic colonography. Ann Intern Med 2005; 142:635-650.
50. Johnson CD, Chen MH, Toledano AY, et al. Accuracy of CT colonography for detection of large adenomas and cancers. N Engl J Med. 2008; 259:1207-1217.
51. Zitt M, Zitt M, Muller HM. DNA methylation in colorectal cancer- Impact on screening and therapy monitoring modalities? Disease Markers 2007;23:51-71.
52. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990;61:759-767.
53. Lengauer C, Kinzler KW, Vogelstein B. Genetic instabilities in human cancers. Nature 1998;396:643-649.
54. Wilson JM and Junger G. Principles and Practice of Screening for Disease. Geneva, Switzerland:World Health Organization; 1968.
55. Morikawa T, Kato J, Yamiji Y, et al. A comparison of the immunochemical fecal occult blood test and total colonoscopy in the asymptomatic population. Gastroenterology 2005; 129:422-428.
56. Qaseem A, Denberg TD, Hopkins Jr RH, Humphrey LL, Levine J, Sweet DE, and Shekelle P. Screening for Colorectal Cancer:A Guidance Statement from the American College of Physicians. Ann Intern Med 2012; 156:378-386
57. [Internet] US Preventive Services Task Force. Screening for colorectal cancer. Rockville, MD:Agency for Healthcare Research and Quality; 2008. www.uspreventiveservicestaskforce.org/uspstf/uspscolo.htm.
58. Slattery ML, Curtin K, Anderson K et al. Associations between cigarette smoking, lifestyle factors, and microsatellite instability in colon tumors. J Natl Cancer Inst 2000; 92:1831 - 6.
59. Giovannucci E. An updated review of the epidemiological evidence that cigarette smoking increases risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev 2001; 10:725 - 31.
60. Campbell RJ, Ferrante JM, Gonzalez EC et al. Predictors of advanced stage colorectal cancer diagnosis:results of a population-based study. Cancer Detect Prev 2001; 25:430- 8.
61. Anderson JC, Alpern Z, Messina CR et al. Predictors of proximal neoplasia in patients without distal adenomatous pathology. Am J Gastroenterol 2004; 99:472 -7.
62. Giovannucci E. Nutrition, Insulin, Insulin-Like Growth Factors and Colon Cancer:A Review of the Evidence. Horm Metab Res 2003; 35:694-704
63. Giovannucci E. Insulin, Insulin-Like Growth Factors and Colon Cancer:A Review of the Evidence. J Nutr 2001; 131:3109s-3120s
64. Schoen RE, Tangen CM, Kuler LH et al. Increased blood glucose, insulin, body size and incidental colon cancer. J Natl Cancer Inst 1999; 91:1147-54
65. Siddiqui AA. Metabolic Syndrome and its Association with Cancer:A Review. Am J Med Sci March 2011; 341 (3):227-231
66. Bird CL, Frankl HD, Lee ER et al. Obesity, weight gain, large weight changes, and adenomatous polyps of the left colon and rectum. Am J Epidemiol 1998; 147:670 -80.
67. Shinchi K Kono S, Honjo S et al. Obesity and adenomatous polyps of the sigmoid colon. Jpn J Cancer Res 1994; 85:479 -84.
68. Neugut AI, Lee WC, Garbowski GC et al. Obesitous polyps. J Natl Cancer Inst 1991; 83:359-61.
69. Lansdorp-Vogelaar I, Knudson AB and Brenner H. Cost-effectiveness of Colorectal Cancer Screening. Epidemiol Rev 2001; 33(1):88-100.
70. Ko CW, Kreuter W, Baldwin LM. Persistent demographic differences in colorectal cancer screening utilization despite Medicare reimbursement. BMC Gastroenterol. 2005; 5:10.
71. Ko CW, Kreuter W, Baldwin LM. Effect of Medicare coverage on use of invasive colorectal cancer screening tests. Arch Intern Med. 2002; 162(22):2581-6.
72. Schneider EC, Rosenthal M, Gatsonis CG, Zheng J, Epstein AM. Is the type of Medicare insurance associated with colorectal cancer screening prevalence and selection of screening strategy? Med Care. 2008 Sep; 46(9 Suppl 1):S84-90.
73. Brounts LR, Lehmann RK, Lesperance KE, Brown TA and Steele SR. Improved Rates of Colorectal Cancer Screening in an equal access population. Am J Surgery 2009 197:609-613.
74. [Internet] Rise LAG, Eisner MP, Kosary CL et al. SEER Cancer statistics review, 1975-2000, Bethesda (MD):National Cancer Institute. http://seer.cancer.gov/csr/1975-2000, 2003.
75. Agrawal S Bhupinderjit A, Bhutani MS, Boardman L, Nguyen C, Romero Y, Srinivasan R, Figueroa-Moseley C. Colorectal Cancer in African Americans. Am J Gastroenterol 2005; 100:515-523
76. Theuer CP, Wagner JL, Taylor TH, Brewster WR, Tran D, McLaren CE and Anton-Culver H. Racial and Ethnic CRC patterns affect the cost-effectiveness of CRC screening in the US. Gastroenterology 2001; 120:848-56
77. Hassan MO and Steele SR. Race does not impact CRC treatment or outcomes with equal access. Am J Surgery 2009 197:485-490
78. Bastaini R, Gallardo NV, Maxwell AE. Barriers to Colorectal Cancer Screening Among African American. J Psycho Oncol 2001; 19:113-32
79. [Internet] US Census Bureau. US Hispanic Population Surpasses 45 Million Now Fifteen Percent Total. http://www.census.govxs/newsroom/releases/archives/population/cb08-67.html
80. Goel MS, Wee CC, McCarthy EP, Davis RB, Ngo-Metzger Q, Phillips RS:Racial and ethnic disparities in cancer screening:the importance of foreign birth as a barrier to care. J Gen Intern Med. 2003; 18:1028-1035.
81. Swan J, Breen N, Coates RJ, Rimer BK, Lee NC:Progress in cancer screening practices in the United States:results from the 2000 National Health Interview Survey. Cancer. 2003; 97:1528-1540.
82. Reyes-Ortiz CA, Eschbach K, Zhang DD, Goodwin JS:Neighborhood composition and cancer among Hispanics:tumor stage and size at time of diagnosis. Cancer Epidemiol Biomarkers Prev. 2008; 17:2931-2936.
83. Stefanidis D, Pollock BH, Miranda J, et al. Colorectal cancer in Hispanics:a population at risk for earlier onset, advanced disease, and decreased survival. Am J Clin Oncol. 2006; 29:123-126.
84. Coughlin SS, Costanza ME, Fernandez ME, et al. CDC-funded intervention research aimed at promoting colorectal cancer screening in communities. Cancer. 2006; 107:1196-1204.
85. Miller SE, Hager P, Lopez K, Salinas J, Shepherd WL:The past, present, and future of comprehensive cancer control from the state and tribal perspective. Prev Chronic Dis. 2009; 6:A112.
86. Townsend JS, Richardson LC, Steele CB, White DE:Evidence-based interventions and screening recommendations for colorectal cancer in comprehensive cancer control plans:a content analysis. Prev Chronic Dis. 2009; 6:A127.
87. Zhou J, Enewold L, Peoples GE, McLeod DG, Potter JF, Steele RS, Clive KS, Stojandinovic A and Zhu K. Colorectal, Prostate and Skin Cancer Screening among Hispanic and White Non-Hispanic Men, 2000-2005. J Natl Med Assoc 2011; 103:343-350.
88. Shah M, Zhu K, Potter J:Hispanic acculturation and utilization of colorectal cancer screening in the United States. Cancer Detect Prev. 2006; 30:306-312.
89. Cameron KA, Francis L, Wolf MS, Baker DW, Makoul G:Investigating Hispanic/Latino perceptions about colorectal cancer screening:a community- based approach to effective message design. Patient Educ Couns. 2007; 68:145-152.
90. Jerant AF, Arellanes RE, Franks P:Factors associated with Hispanic/non-Hispanic white colorectal cancer screening disparities. J Gen Intern Med. 2008; 23:1241-1245.
91. Walsh JM, Kaplan CP, Nguyen B, Gildengorin G, McPhee SJ, Perez- Stable EJ:Barriers to colorectal cancer screening in Latino and Vietnamese Americans. Compared with non-Latino white Americans. J Gen Intern Med. 2004; 19:156-166.
92. Vanderpool RC, Kornfeld J, Rutten LF, Squiers L:Cancer information- seeking experiences:the implications of Hispanic ethnicity and Spanish language. J Cancer Educ. 2009; 24:141-147.
93. Davis SW, Diaz-Mendez M, Garcia MT:Barriers to seeking cancer information among Spanish-speaking cancer survivors. J Cancer Educ. 2009; 24:167-171.
94. Hopwood CJ, Flato CG, Ambwani S, Garland BH, Morey LC:A comparison of Latino and Anglo socially desirable responding. J Clin Psychol. 2009; 65:769-780.
95. Velasquez RJ, Callahan WJ, Young R:Hispanic-white MMPI comparisons:does psychiatric diagnosis make a difference?. J Clin Psychol. 1993; 49:528-534
96. Homayoon B et al. Impact of Asian Ethnicity on CRC Screening. Am J Clin Oncol 2012.
97. Best Jr., Richard A. Military Medical Care Services:Questions and Answers (2005-05-05). Congressional Research Service. 2005.
98. United States Department of Defense. Task Force on the Future of Military Health Care:Final Report. 2007.
99. [Internet] Official website of the Tricare Management Activity. What is TRICARE? http://www.tricare.mil/tma/.
100. [Internet] http://www.health.mil/About_MHS/FAQs.aspx
101. [Internet] The Quadruple Aim:Working Together, Achieving Success MHS 2011 Stakeholders Report. http://health.mil/About_MHS/StakeholdersReport.aspx
102. El-Serag H, Petersen L, Hampel H, Richardson P and Cooper G. The Use of Screening Colonoscopy for Patients Cared for by the Department of Veterans Affairs. Arch Intern Med 2006; 166:2202-2208.
103. [Internet] http://www.va.gov/health/aboutVHA.asp.
104. Hoffman RM, Steel SR, Yee EF, Massie L, Schrader RM, Moffett ML, Murata GH. System-based Intervention to Improve CRC Screening Uptake. Am J Manag Care 2011 Jan; 17 (1):49-55
105. Lee JK, Reis V, Liu S, Conn L, Groessl EJ, Ganiats TG, Ho SB. Improving FOBT Testing Compliance Using Mailed Education Reminder. J Gen Intern Med 2009 Nov; 24 (11):1192-1197
106. Lee JK, Groessl EJ, Ganiats TG and Ho BS. Cost-effectiveness of Mailed Education Reminder to Increase CRC. BMC Gastroenterol 2011 Aug 25; 11:93
107. [Internet] The NHS Constitution for England, (2012 Edition). http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_132961
108. Logan RFA, Patnick J, Nickerson C, Coleman C, Rutter MD and von Wagner C. Outcomes of the Bowel Cancer Screening Program (BCSP) in England after the first 1 million tests. Gut 2012 Oct;61(10):1439-46.
109. Segnan N, Armaroli P, Bonelli L, et al. Once-only sigmoidoscopy in colorectal cancer screening:follow-up findings of the Italian randomized controlled trial-SCORE. J Natl Cancer Inst. 2011; 103(17):1310-1322.
110. Church TR. Screening for Colorectal Cancer-Which Strategy is Best? JNCI Sept 2011; 103 (17):1282-1283.
111. Whyte S, Chilcott J, Halloran S. Reappraisal of Options for Colorectal Cancer Screening in England. Colorectal Dis 2012 ; Epub ahead of print
112. Moiel D and Thompson J. Early Detection of Colon Cancer-The Kaiser Permanente Northwest 30-Year History:How Do We Measure Success? Is It the Test, the Number of Tests, the Stage, or the Percentage of Screen-Detected Patients? The Permanente Journal Fall 2011; 15 (4):30-38.